Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Allen Ho, MD
Retina Diagnostic & Treatment Associates, LLC
Principal Investigator - Andrew Strong, Ph.D
QLT Inc.
Study Chair - Henry Hudson, MD
Retina Centers, PC
Principal Investigator - Oscar Cuzzani, MD
QLT Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Calgary, Alberta, Canada
- Facility name not stated
Vancouver, British Columbia, Canada
- Facility name not stated
Halifax, Nova Scotia, Canada
- Facility name not stated
London, Ontario, Canada
- Facility name not stated
Toronto, Ontario, Canada
- Facility name not stated
Mobile, Alabama, United States
- Facility name not stated
Phoenix, Arizona, United States
- Retina Centers, Pc
Tucson, Arizona, United States
- Facility name not stated
Beverly Hills, California, United States
- Facility name not stated
Campbell, California, United States
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
Poway, California, United States
- Facility name not stated
Sacramento, California, United States
- Facility name not stated
Torrance, California, United States
- Facility name not stated
Fort Myers, Florida, United States
- Facility name not stated
Indianapolis, Indiana, United States
- Facility name not stated
Davenport, Iowa, United States
- Facility name not stated
Missoula, Montana, United States
- Facility name not stated
Omaha, Nebraska, United States
- Facility name not stated
Portsmouth, New Hampshire, United States
- Facility name not stated
Portland, Oregon, United States
- Facility name not stated
Philadelphia, Pennsylvania, United States
- Facility name not stated
West Mifflin, Pennsylvania, United States
- Facility name not stated
Arlington, Texas, United States
- Facility name not stated
Temple, Texas, United States
- Facility name not stated
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2007
- Primary completion
- 31 May 2009
- Completion
- 31 May 2010
- Last update posted
- 2 Jun 2011
- Registered enrollment
- 162
- Registry id
- NCT00492284
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.